Strength
250 mg/5mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762505007
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
GABAPENTINApproval Type
Authorized Generic (NDA)
FDA Application
NDA021129On Market Since
7/1/2022
Pharmacological Classes
Decreased Central Nervous System Disorganized Electrical Activity
Related Drugs
Same classification
GABAPENTIN 100 MG CAPSULE
Generic
00480349405•Teva Pharmaceuticals USA Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
00904666561•Major Pharmaceuticals
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066101•NorthStar Rx LLC
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066102•NorthStar Rx LLC
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
42385097201•Laurus Labs Limited
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
42385097205•Laurus Labs Limited
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
42385097211•Laurus Labs Limited
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
45963055511•Actavis Pharma, Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
45963055550•Actavis Pharma, Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
50228017901•ScieGen Pharmaceuticals, Inc.
$0.0211
per EA